← Evidence map

TrialMicrobiome2020

Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial.

Suryang Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32862830